Search :
Sign in or Register  
Welcome Sign in or Don't have an account?Register

ERCC4

The protein encoded by this gene forms a complex with ERCC1 and is involved in the 5' incision made during nucleotide excision repair. This complex is a structure specific DNA repair endonuclease that interacts with EME1. Defects in this gene are a cause of xeroderma pigmentosum complementation group F (XP-F), or xeroderma pigmentosum VI (XP6).[provided by RefSeq, Mar 2009]
Full Name
ERCC Excision Repair 4, Endonuclease Catalytic Subunit
Research Area
Catalytic component of a structure-specific DNA repair endonuclease responsible for the 5-prime incision during DNA repair. Involved in homologous recombination that assists in removing interstrand cross-link.
Biological Process
Cellular response to UV Source: BHF-UCL
DNA repair Source: UniProtKB
Double-strand break repair via homologous recombination Source: UniProtKB
Double-strand break repair via nonhomologous end joining Source: BHF-UCL
Negative regulation of double-stranded telomeric DNA binding Source: BHF-UCL
Negative regulation of protection from non-homologous end joining at telomere Source: BHF-UCL
Negative regulation of telomerase activity Source: GOC
Negative regulation of telomere maintenance Source: UniProtKB
Negative regulation of telomere maintenance via telomere lengthening Source: BHF-UCL
Nucleotide-excision repair Source: MGI
Nucleotide-excision repair, DNA incision Source: UniProtKB
Nucleotide-excision repair, DNA incision, 3'-to lesion Source: UniProtKB
Nucleotide-excision repair, DNA incision, 5'-to lesion Source: UniProtKB
Nucleotide-excision repair involved in interstrand cross-link repair Source: GO_Central
Regulation of autophagy Source: Ensembl
Resolution of meiotic recombination intermediates Source: GO_Central
Response to UV Source: UniProtKB
Telomere maintenance Source: BHF-UCL
Telomeric DNA-containing double minutes formation Source: BHF-UCL
UV protection Source: Ensembl
Cellular Location
Nucleus
Involvement in disease
Xeroderma pigmentosum complementation group F (XP-F):
An autosomal recessive pigmentary skin disorder characterized by solar hypersensitivity of the skin, high predisposition for developing cancers on areas exposed to sunlight and, in some cases, neurological abnormalities. The skin develops marked freckling and other pigmentation abnormalities. XP-F patients show a mild phenotype.
XFE progeroid syndrome (XFEPS):
A syndrome characterized by aged bird-like facies, lack of subcutaneous fat, dwarfism, cachexia and microcephaly. Additional features include sun-sensitivity from birth, learning disabilities, hearing loss, and visual impairment.
Xeroderma pigmentosum type F/Cockayne syndrome (XPF/CS):
A variant form of Cockayne syndrome, a disorder characterized by growth retardation, microcephaly, impairment of nervous system development, pigmentary retinopathy, peculiar facies, and progeria together with abnormal skin photosensitivity. Cockayne syndrome dermatological features are milder than those in xeroderma pigmentosum and skin cancers are not found in affected individuals. XPF/CS patients, however, present with severe skin phenotypes, including severe photosensitivity, abnormal skin pigmentation, and skin cancer predisposition.
Fanconi anemia complementation group Q (FANCQ):
A disorder affecting all bone marrow elements and resulting in anemia, leukopenia and thrombopenia. It is associated with cardiac, renal and limb malformations, dermal pigmentary changes, and a predisposition to the development of malignancies. At the cellular level it is associated with hypersensitivity to DNA-damaging agents, chromosomal instability (increased chromosome breakage) and defective DNA repair.

Anti-ERCC4 antibodies

+ Filters
Loading...
Submit A Review Fig.3 Signaling pathways in cancers. (Creative Biolabs Authorized) Fig.4 Protocols troubleshootings & guides. (Creative Biolabs Authorized) Submit A Review Fig.3 Signaling pathways in cancers. (Creative Biolabs Authorized) Fig.4 Protocols troubleshootings & guides. (Creative Biolabs Authorized)
Target: ERCC4
Host: Rabbit
Antibody Isotype: IgG
Specificity: Human, Rat, Monkey
Clone: D3G8C
Application*: WB
Target: ERCC4
Host: Mouse
Antibody Isotype: IgG2, κ
Specificity: Human
Clone: 3F397
Application*: IH, WB
Target: ERCC4
Host: Mouse
Antibody Isotype: IgG2b
Specificity: Human
Clone: 3F398
Application*: WB
Target: ERCC4
Host: Mouse
Antibody Isotype: IgG2b
Specificity: Human
Clone: UMAB22
Application*: WB, IF, F, IH
Target: ERCC4
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human, Dog, Rat, Monkey, Mouse
Clone: UMAB21
Application*: WB, IF, F, IH
Target: ERCC4
Host: Mouse
Antibody Isotype: IgG2a
Specificity: Human, Dog, Rat, Monkey, Mouse
Clone: UMAB20
Application*: WB, IF, F, IH
Target: ERCC4
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human
Clone: 4H4
Application*: ICC, IF
Target: ERCC4
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human
Clone: 3H7
Application*: WB, F
Target: ERCC4
Host: Mouse
Antibody Isotype: IgG2a
Specificity: Human, Mouse
Clone: 4E11
Application*: WB, F, IH, ICC, IF
Target: ERCC4
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human
Clone: 3F2/3
Application*: WB, E, IH, ICC, IF
Target: ERCC4
Host: Mouse
Antibody Isotype: IgG2b
Specificity: Human
Clone: 51
Application*: WB
Target: ERCC4
Host: Mouse
Antibody Isotype: IgG2a
Specificity: Human
Clone: SPM228
Application*: WB, IP, P, F, ICC, IF
Target: ERCC4
Host: Mouse
Antibody Isotype: IgG2a, κ
Specificity: Human
Clone: CBFYE-1166
Application*: P, WB
Target: ERCC4
Host: Mouse
Antibody Isotype: IgG2a
Specificity: Human
Clone: CBFYE-1164
Application*: C, IP, WB
Target: ERCC4
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human, Dog, Rat, Monkey, Mouse
Clone: CBFYE-1163
Application*: F, IF, WB
Target: ERCC4
Host: Mouse
Antibody Isotype: IgG2a
Specificity: Human, Dog, Rat, Monkey, Mouse
Clone: CBFYE-1162
Application*: WB, IF, F
Target: ERCC4
Host: Mouse
Antibody Isotype: IgG2, κ
Specificity: Human
Clone: CBFYE-0252
Application*: P, WB
Target: ERCC4
Host: Mouse
Antibody Isotype: IgG2b
Specificity: Human
Clone: OTI6E6
Application*: WB, IH, IF, F
More Infomation
For Research Use Only. Not For Clinical Use.
(P): Predicted
* Abbreviations
IFImmunofluorescence
IHImmunohistochemistry
IPImmunoprecipitation
WBWestern Blot
EELISA
MMicroarray
CIChromatin Immunoprecipitation
FFlow Cytometry
FNFunction Assay
IDImmunodiffusion
RRadioimmunoassay
TCTissue Culture
GSGel Supershift
NNeutralization
BBlocking
AActivation
IInhibition
DDepletion
ESELISpot
DBDot Blot
MCMass Cytometry/CyTOF
CTCytotoxicity
SStimulation
AGAgonist
APApoptosis
IMImmunomicroscopy
BABioassay
CSCostimulation
EMElectron Microscopy
IEImmunoelectrophoresis
PAPeptide Array
ICImmunocytochemistry
PEPeptide ELISA
MDMeDIP
SHIn situ hybridization
IAEnzyme Immunoassay
SEsandwich ELISA
PLProximity Ligation Assay
ECELISA(Cap)
EDELISA(Det)
BIBioimaging
IOImmunoassay
LFLateral Flow Immunoassay
LALuminex Assay
CImmunohistochemistry-Frozen Sections
PImmunohistologyp-Paraffin Sections
ISIntracellular Staining for Flow Cytometry
MSElectrophoretic Mobility Shift Assay
RIRNA Binding Protein Immunoprecipitation (RIP)
Online Inquiry